@article{Ali_2024b,

title = {Effectiveness, utility, and economic analysis of three-drug treatment vs two-drug treatment in chronic obstructive pulmonary disease patients},

author = {Syed Aamir Ali and Subhranshu Panda and M. Aleemuddin Naveed},

url = {https://www.ijrc.in/doi/IJRC/pdf/10.5005/jp-journals-11010-1126},

doi = {10.5005/jp-journals-11010-1126},

issn = {2277-9019},

year  = {2024},

date = {2024-09-30},

urldate = {2024-09-30},

journal = {Indian Journal of Respiratory Care},

volume = {13},

issue = {3},

pages = {146-151},

abstract = {Aim and background: Inhaled corticosteroids (ICS) and bronchodilators remain the mainstay of therapeutic modalities available for the management of chronic obstructive pulmonary disease (COPD). This study aimed to evaluate the effectiveness, utility, and economic analysis of a three-drug treatment vs a two-drug treatment in COPD patients. Materials and methods: An observation was conducted at a superspecialty hospital in Hyderabad. Out of the 115 patients recruited from the inpatient and outpatient wards of the Pulmonology Department, 55 patients received triple therapy containing ICS, long-acting β-agonists (LABA), and long-acting muscarinic antagonists (LAMA), whereas 60 patients were treated with dual therapy comprising ICS/LABA. Cost-effectiveness was assessed based on forced expiratory volume in 1 second (FEV1) (FEV1% predicted), St George's respiratory questionnaire (SGRQ) scores, SGRQ responder ratio, COPD assessment test (CAT) scores, and incremental cost-effectiveness ratio (ICER). Results: Results signified the enhanced potency of three-drug treatment vs two-drug treatment as proven by the improvement in average difference from initial values in (1) FEV1% predicted value of 4.36 [95% confidence interval (CI) (2.9–5.82)], (2) SGRQ scores of −6.76 [95% CI (−2.14 to −11.38)], SGRQ responder ratio of 13.25 (3.72–47.24), CAT scores of −5.15 [95% CI (−9.87 to −0.43)] and ICER of 3522 [95% CI (14682 to −7638)]. Conclusion: Triple therapy comprising LABA, LAMA, and ICS can optimize lung function and improve clinical outcomes, leading to overall enhancement of well-being compared to LABA/ICS dual therapy in moderate to severe COPD patients. Clinical significance: Three-drug treatment comprising ICS/LABA/LAMA is an effective and cost-effective therapeutic approach for managing moderate and severe COPD compared to ICS/LABA dual therapy. This is evidenced by improvements in spirometry values (FEV1% predicted) and health-related quality of life (HRQoL).},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Basith_2024,

title = {Efficacy of Tru-cut biopsy of the cervical lymphnodes over FNAC for detecting MTB using CBNAAT histopathology and cultures},

author = {Mohammed Abdul Basith and M. Aleemuddin Naveed and Ashfaq Hasan and Fahad Abdullah Bin Breik and Syed Mahmood Ahmed and Shireen Adeeb Mujtaba Ali},

url = {https://journals.lww.com/jdyu/fulltext/2024/13030/efficacy_of_tru_cut_biopsy_of_the_cervical.11.aspx},

doi = {10.4103/jdrysruhs.jdrysruhs_32_24},

issn = {2950-5356},

year  = {2024},

date = {2024-09-27},

urldate = {2024-07-01},

journal = {Journal of Dr. YSR University of Health Sciences},

volume = {13},

issue = {3},

pages = {247–252},

publisher = {Wolters Kluwer - Medknow},

abstract = {Introduction: The present study was carried out to see the usefulness of Tru-cut biopsy over fine needle aspiration (FNA) in diagnoses of tuberculosis (TB) cervical lymphadenopathy and comparing their yields by performing ZN staining, culture, cytology, histopathology, and CBNAAT.

Observation and Results: It was found that the yield of Tru cut was significantly more in ZN staining and histopathology. Even though the yield was more in culture and CBNAAT also, it was not statistically significant. FNA is a popular method which is very widely used, but it has a low yield. From the results, it was inferred that for FNA, the positive rate was 27.6%, 38.4%, 67.7%, and 43% for the four modalities of ZN staining, CBNAAT, cytology, and acid-fast bacilli cultures, respectively. Comparatively, for Tru-cut biopsy, the positive rate was 36.9%, 46.2%, 92.3%, and 47.7%, respectively, in all four modalities. It was noticed that the highest value was recorded for histopathology, followed by culture and CBNAAT for Tru-cut biopsy procedures. Comparatively, FNA showed the highest negative rate for ZN staining and CBNAAT.

Conclusion: The present study also highlights the importance of Tru-cut biopsy over FNA. It is one of the emerging techniques which if used properly could offer a better yield. Further results and conclusions are discussed in the paper.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Vuppala_2024,

title = {Clinico-demographic profile and outcome of acute pediatric hydrocarbon poisoning in South India},

author = {Anil Kumar Vuppala and Rama Krishna Nelakurthi and Shalini Akunuri and Ahlaam Arif and M. Aleemuddin Naveed},

url = {https://www.publichealthtoxicology.com/pdf-189940-111867?filename=Clinico_demographic.pdf},

doi = {10.18332/pht/189940},

issn = {2732-8929},

year  = {2024},

date = {2024-06-28},

urldate = {2024-06-28},

journal = {Public Health Toxicology},

volume = {4},

issue = {2},

pages = {1-6},

abstract = {Introduction: Acute hydrocarbon poisoning in children is an important cause of morbidity and mortality in developing countries. This study aimed to understand clinico-demographic profile and outcome of acute hydrocarbon poisoning in children belonging to low-middle economy families from South India. Methods:

A prospective observational study was conducted over 18 months from January 2022 to June 2023 in a private medical college from South India for children between 1 month and 18 years of age admitted with a history of acute hydrocarbon poisoning. Results: Out of 1568 admissions, 29 children had acute hydrocarbon poisoning. Median age was 2.6 years (range: 6 months-15year). The majority (58.6%) belonged to toddler age group. The male-to-female ratio was 1.6:1. Most (48.3%) cases were seen during summer. All poisonings were accidental and occurred via the ingestion route. Paint thinner (75.9%) and mosquito repellent (20.7%) were the most common agents implicated. Vomiting (69%), cough (24.1%), and respiratory distress (20.7%) were the predominant symptoms noted. Chest radiograph was abnormal in 10% of patients. Respiratory support was provided in 44% of patients. 70% of patients were discharged within 24 hours. There was no mortality. Conclusions: Acute hydrocarbon poisoning is a preventable cause of mortality and morbidity in children. The majority of cases occur in the toddler age group and are accidental. Most patients improve with simple conservative measures. Following unit protocols for the management avoids unnecessary investigations, and medications and promotes early discharge.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Jindal_2023,

title = {Scoring system for the use of nebulizers in the primary care settings: an expert consensus statement},

author = {Surinder K. Jindal and Shrikant Pawar and Ashfaq Hasan and Aloke Ghoshal and Raja Dhar and Subodh K. Katiyar and K. S. Satish and Deepak Talwar and Sundeep Salvi},

url = {https://pubmed.ncbi.nlm.nih.gov/37355847/},

doi = {10.5005/japi-11001-0273 },

issn = {0004-5772},

year  = {2023},

date = {2023-06-30},

urldate = {2023-06-30},

journal = {Journal of the Association of Physicians of India},

volume = {71},

issue = {6},

pages = {11-12},

abstract = {Background: The use of nebulizers is an important and useful method for delivering drugs to the lungs in patients with various airway and lung parenchymal disorders. They are primarily used in patients with acute symptoms and in a selected group of patients for maintenance treatment.Its use has increased, especially during the coronavirus disease 2019 (COVID-19) pandemic. To ensure the appropriate use of nebulizers by primary care physicians and to guide them, we aimed to develop a simple nebulizer use score.Methods: An expert working group (EWG) of pulmonologists were formed who using a semi-Delphi method, developed a list of variables and a cut-off score to decide when to use nebulizers. We started with a total of 55 variables that were developed through an exhaustive review of the literature. These were further reduced to smaller numbers that had the maximum score as well as concordance with the EWG. The scores ranged from 1 to 10 (completely disagree to completely agree), and only those above 7.5 were selected.Results: A total of 8 variables with the highest scores were selected (Table 1), which had a total maximum score of 40. A score of <15 was suggested to indicate no use of nebulizer and >20 to suggest definite use of nebulizer. A score between 15 and 20 was suggested for physician judgment.A separate table of 12 conditions was made where the use of nebulizers was mandatory.Conclusion: This first-of-its-kind nebulizer score can be used by primary care physicians to decide which patients should be put on nebulizer treatment.},

key = {pmid37355847},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Naveed_2022,

title = {Sputum culture and antibiogram in infective acute exacerbation of chronic obstructive pulmonary disease in a tertiary care hospital in India},

author = {M. Aleemuddin Naveed and Syed Aamir Ali and Urooj Ahmedi and Syed Mujtaba Quadri and Kashifa Butool and Qursheed Sultana },

url = {https://www.ijcdas.com/doi/pdf/10.5005/ijcdas-60-1-13},

doi = {10.5005/ijcdas-60-1-13},

issn = {0377-9343},

year  = {2022},

date = {2022-11-01},

urldate = {2022-11-01},

journal = {The Indian Journal of Chest Diseases and Allied Sciences},

volume = {60},

issue = {1},

pages = {13-18},

publisher = {Jaypee Brothers Medical Publishing},

abstract = {Background. Infections are the common cause of death in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).Methods. A prospective cohort study was conducted on 100 patients with AECOPD in a tertiary care hospital in Hyderabad city in South India. Sputum culture of 100 patients was evaluated for the presence of Gram-positive and Gram-negative micro-organisms. Sensitivity and resistance patterns of the micro-organisms against commonly used antibiotics were also investigated.Results. During the period October 2015 to April 2016, 67% of the patients had sputum culture positive for the presence of pathogenic micro-organisms. Pathogens, most commonly, isolated were Gram-negative organisms like Klebsiella oxytoca (13%), followed by Klebsiella species (11%) and Klebsiella pneumoniae (10%). Amikacin was found to be the most effective antibiotic against all micro-organisms. A significantly higher proportion of organisms were pathogenic compared to non-pathogenic organisms (p=0.0014). Among pathogenic organisms, a significantly higher proportion of Gram-positive organisms were found compared to Gram-negative organisms (p=0.0180). Pathogenic micro-organisms showed a high resistance rate to commonly used antibiotics. Except few strains of Klebsiella, Pseudomonas and Streptococcus, overall 62.9% strains were sensitive to doxycycline.Conclusions. Our observations suggest that doxycycline can be used as an empirical antibiotic in the treatment of AECOPD.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Dhar_2022,

title = {Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry},

author = {Raja Dhar and Sheetu Singh and Deepak Talwar and B. V. Murali Mohan and Surya Kant Tripathi and Rajesh Swarnakar and Sonali Trivedi and Srinivas Rajagopala and George D'Souza and Arjun Padmanabhan and B. Archana and P. A. Mahesh and Babaji Ghewade and Girija Nair and Aditya Jindal and Gayathri Devi H. Jayadevappa and Honney Sawhney and Kripesh Ranjan Sarmah and Kaushik Saha and Suresh Anantharaj and Arjun Khanna and Samir Gami and Arti Shah and Arpan Shah and Naveen Dutt and Himanshu Garg and Sunil Vyas and Kummannoor Venugopal and Rajendra Prasad and M. Aleemuddin Naveed and Saurabh Karmakar and Virendra Singh and S. K. Jindal and Shubham Sharma and Deepak Prajapat and Sagar Chandrashekar and Michael Loebinger and Aditi Mishra and Francesco Blasi and Ramanathan Palaniappan Ramanathan and Pieter C. Goeminne and Preethi Vasudev and Amelia Shoemark and B. S. Jayaraj and Rahul Kungwani and Akanksha Das and Mehneet Sawhney and Eva Polverino and Tobias Welte and Nayan Sri Gulecha and Michal Shteinberg and Anshul Mangala and Palak Shah and Nishant Kumar Chauhan and Nikita Jajodia and Ashutosh Singhal and Sakshi Batra and Ashfaq Hasan and Stefano Aliberti and Megan L. Crichton and Sneha Limaye and Sundeep Salvi and James D. Chalmers},

url = {https://erj.ersjournals.com/content/erj/61/1/2200611.full.pdf},

doi = {10.1183/13993003.00611-2022},

issn = {0903-1936},

year  = {2022},

date = {2022-10-01},

urldate = {2022-10-01},

journal = {European Respiratory Journal},

volume = {61},

issue = {1},

pages = {2200611},

publisher = {European Respiratory Society (ERS)},

abstract = {Background Identifying risk factors for poor outcomes can help with risk stratification and targeting of treatment. Risk factors for mortality and exacerbations have been identified in bronchiectasis but have been almost exclusively studied in European and North American populations. This study investigated the risk factors for poor outcome in a large population of bronchiectasis patients enrolled in India.

Methods The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India (EMBARC-India) registry is a prospective observational study of adults with computed tomography-confirmed bronchiectasis enrolled at 31 sites across India. Baseline characteristics of patients were used to investigate associations with key clinical outcomes: mortality, severe exacerbations requiring hospital admission, overall exacerbation frequency and decline in forced expiratory volume in 1 s.

Results 1018 patients with at least 12-month follow-up data were enrolled in the follow-up study. Frequent exacerbations (≥3 per year) at baseline were associated with an increased risk of mortality (hazard ratio (HR) 3.23, 95% CI 1.39–7.50), severe exacerbations (HR 2.71, 95% CI 1.92–3.83), future exacerbations (incidence rate ratio (IRR) 3.08, 95% CI 2.36–4.01) and lung function decline. Coexisting COPD, dyspnoea and current cigarette smoking were similarly associated with a worse outcome across all end-points studied. Additional predictors of mortality and severe exacerbations were increasing age and cardiovascular comorbidity. Infection with Gram-negative pathogens (predominantly Klebsiella pneumoniae) was independently associated with increased mortality (HR 3.13, 95% CI 1.62–6.06), while Pseudomonas aeruginosa infection was associated with severe exacerbations (HR 1.41, 95% CI 1.01–1.97) and overall exacerbation rate (IRR 1.47, 95% CI 1.13–1.91).

Conclusions This study identifies risk factors for morbidity and mortality among bronchiectasis patients in India. Identification of these risk factors may support treatment approaches optimised to an Asian setting.},

key = {pmid36229049},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Ali_2022c,

title = {Role of circulatory miRNA-21 and associated signaling pathways in the pathogenesis of pulmonary fibrosis among individuals recovered after COVID-19 infection},

author = {Mohammad Ali and Fahad Abdullah Bin Breik and M. Aleemuddin Naveed and Syed Mahmood Ahmed and Aleem Ahmed Khan and Ashfaq Hasan},

url = {https://pdf.sciencedirectassets.com/781323/1-s2.0-S2773044122X00041/1-s2.0-S2773044122000675/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEGEaCXVzLWVhc3QtMSJGMEQCIE0LJ%2BCvVLB86Touyqcy2AguFweYOYjtUTEMTkViqBbbAiAI%2BAvwB315j9dC9Se4lbm9nDydykFzM1oYJsMEVqzKmCqyBQhaEAUaDDA1OTAwMzU0Njg2NSIMq8cixabBNQ%2FFlP7RKo8F4tHFQ2XCEX%2BnNUv%2Fo5kJzDriDFR%2B4esGfpxvWYZe2iJLDcqko4%2FKj6UJNujCCeczxRju1D5fVB%2BeBslzhdQvE7hnh%2F%2FnzV7nqibmZXBDBzsscCcFaUKkvp6kTveTxyA2rUH4diDkXnrrhgfmOX2eisr7Qhmd%2F0AcaREv%2BO%2FmbdqUbKMsbAkTgrzYw8Yx9qK%2BgJYzk19T300hlFdoGGGafOWk8DK9wuY5JSMb96a1S%2Bm1kTBHrmHg7dvRgmq2I1GbV2y10AY3eLayG%2FhLZNqxy%2FswXa16YVvtYJ6UG8o998uMZe7Zxu%2FLw73%2Fnjd7E0un%2FhMbpOan6kbXc9KEG%2BqVvtXV2NXKxAZBhIwHXMsDyyt16dwdwcE5f9pLP7vBhiEuK4SbFC0Xo1t4sc2wKNY3uCh0GPpTDa%2FTLWgyY0sPMImc%2FyZ8RjKKL4hrQkmVoNqFqLgdsOPVsqoMxmYbErD0EbMwwVf%2FRBQwSeRKi0Y3CfzAMqOnGUzrghoR9Yha2MG4CpBAHpTaFLIeiuETnxdr7GWzvsEOCqDwtMmoYPKXIEe0aKp%2Fk96I5JniIHBdwlx4OwzzPORgC6qdJ195O9b%2FFvA9zGGsLaNfVhKe3oHRDYapPDQBSvrsgZ7dLldkHOhE0yGQm573V51HZu1i4XdNOLoUje5EzAtEmJe3ALac9yxDO2yu1gI5ygLizO7QtWowln2DDIEwZgfsJguAfo6%2B5YPvapbKcKLXEcCWPik3KBMgkNKvboCwdXor52nrYcUmbVLGGyqbzIMTvWglr5840F4sxHkWbJv%2FBWjbAwTfUtiRfJBEW76e4GNtFK%2FbS7ttN5oHd2D4a%2FjewMBmD5Zb38tmdBC4yNt%2FcndcejUPzTDjk8WoBjqyAdtvZMDfupHhuUIvK8v%2BtQIPbtzLcwwqA8TyxzrCBPad5FAsv%2F3jjLRZkjVmqHwehp4d8QPgKrJYWEfRm8E8Vnuv2c7WxFhoBtYlIoy6CaA3lgtqtbI6j%2F%2FLQ1TZqhk2g5HhF3CyYAU%2FVADQIEPLQ1M6S%2FHxWtEMDZFbrx17lQO1IkEiGEH3k9wxJ11A4Diy3Ny8U3Cvjz1nYvoebZtaoSg%2BCgQtb5jjGEjMJAf7iA5s0MI%3D&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Date=20230925T094841Z&X-Amz-SignedHeaders=host&X-Amz-Expires=300&X-Amz-Credential=ASIAQ3PHCVTYTGSOBQO3%2F20230925%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Signature=aa7b878d5e9909131750691259b7560c6773fade490297b8b03355bffa840587&hash=ec409bf344f4e3f2a9188514ea2f0cce6751ec7906e16403ebe1144637fa97b4&host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61&pii=S2773044122000675&tid=spdf-d9142a09-f0a7-44e7-aade-22a3c5a32970&sid=7685485b9275d2467038aec-c7fdaf004220gxrqb&type=client&tsoh=d3d3LnNjaWVuY2VkaXJlY3QuY29t&ua=0f0d5750005550025154&rr=80c25a55481a2e84&cc=in},

doi = {10.1016/j.humgen.2022.201093},

issn = {2773-0441},

year  = {2022},

date = {2022-07-28},

urldate = {2022-07-28},

journal = {Human Gene},

volume = {34},

pages = {201093},

publisher = {Elsevier BV},

abstract = {Introduction: Currently pulmonary fibrosis in post-COVID individuals represents a crucial milieu of investigation due to long-term associated complications and worse clinical outcome. Lack of studies in Indian population confers a crucial need for elucidating possible targets and mechanisms to explore better management and outcome. Hence, this study aimed to explore the role of circulating miRNA-21 in patients from South India after COVID-19 recovery, while targeting TGF-β signaling pathway involved in the development of pulmonary fibrosis. Methods: This prospective, single centre, hospital-based study enrolled a total of 50 participants in the age group of 50 to 60 years including 25 non-infected controls and 25 patients who were recovered after 3–6 months of COVID-19 infection and presented radiological pulmonary abnormalities. Quantification of miRNA-21 and selected gene transcripts (TGF-β, Col1A2, Col3A1, and α-SMA) was performed in plasma samples of both patients and controls. Results: Significantly increased expression levels of miRNA-21 was observed in patient samples compared to controls (4.50 ± 1.03 vs 12.60 ± 3.52, p < 0.0001) with 72.10% sensitivity and 80.10% specificity. Further, significantly increased levels of central fibrosis regulatory gene transcript TGF-β (0.56 ± 0.27 vs 1.83 ± 0.98), two crucial collagen transcripts Col1A2 (0.62 ± 0.19 vs 1.56 ± 1.00) and Col3A1 (0.61 ± 0.27 vs 1.54 ± 0.89), and α-SMA (0.46 ± 0.17 vs 1.20 ± 0.78) was observed in patients compared to controls. Western-blot analysis also showed almost similar observations at proteins levels. Conclusion: Circulating miRNA-21 may provide crucial insights for elucidating TGF-β mediated pulmonary remodeling involved in the fibrosis development and achieve better clinical outcome for post-COVID patients after recovery, in real-time with high diagnostic accuracy.},

key = {pmid37521444},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Ali_2022d,

title = {Psychometric analysis of clinical chronic obstructive pulmonary disease questionnaire and chronic obstructive pulmonary disease assessment test and its correlation with St. George respiratory questionnaire in chronic obstructive pulmonary disease patients},

author = {Syed Aamir Ali and Hajera Saniya and Khaja Naseeruddin and Sabiha Naaz Sana and Talath Fatima and Syed Mahmood Ahmed and M. Aleemuddin Naveed and Ashfaq Hasan and Fahad Abdullah Bin Breik},

url = {https://www.ijrc.in/doi/pdf/10.4103/ijrc.ijrc_12_22},

doi = {10.4103/ijrc.ijrc_12_22},

issn = {2321-4899},

year  = {2022},

date = {2022-07-28},

urldate = {2022-07-28},

journal = {Indian Journal of Respiratory Care},

volume = {11},

issue = {3},

pages = {224-229},

publisher = {Jaypee Brothers Medical Publishing},

abstract = {Introduction: Chronic obstructive pulmonary disease (COPD) is a disease of respiratory airflow obstruction. There are > 80 tools to measure various aspects of COPD patients well.being. This study aimed to evaluate the reliability and consistency of CAT and clinical COPD questionnaire (CCQ) and their correlation with St. George respiratory questionnaire (SGRQ). Methods: A prospective observational comparative study was conducted for 6 months in the pulmonology department of a tertiary care hospital. The following questionnaires were employed to evaluate the state of health of COPD patients: modified Medical Research Council (mMRC), COPD assessment test (CAT), CCQ, and SGRQ. Consistency and inter.rater reliability of CAT and CCQ scales was performed by taking into account the scores of four assessors. Results: Of the 52 patients included, 96% were male, and 4% were female. Cronbach's alpha was 0.620 (CAT score) and 0.861 (CCQ score). The percentage of patients with an mMRC scale of grade 0, 1, 2, 3, and 4 was 4%, 23%, 38%, 8%, and 27%, respectively. SGRQ showed a moderate correlation with CCQ (0.621) and CAT (0.652) scores. Conclusion: The psychometric properties of CAT and CCQ were consistent and satisfactory. Reliability and internal consistency of CAT and CCQ were good and can be employed easily for examining the health state of COPD patients.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Abdullah_2021,

title = {Prevalence of airway reversibility in connective tissue disease-interstitial lung disease (CTD-ILD)},

author = {Fahad Abdullah Bin Breik and Ashfaq Hasan and Moid Mir Siddiq Ali and Rahmath Fida and Sufia Iram Irshad},

url = {https://sciencescholar.us/journal/index.php/ijhs/article/view/13347/10539},

doi = {10.53730/ijhs.v6ns8.13347},

issn = {2550-696X},

year  = {2021},

date = {2021-12-01},

urldate = {2021-12-01},

journal = {International Journal of Health Sciences},

volume = {6},

issue = {S8},

pages = {4989-4994},

publisher = {Universidad Tecnica de Manabi},

abstract = {Background: Spirometry is the most reproducible and objective measurement of airflow limitation. Improvement in FEV1 and/or FVC by 12% or 200ml after using bronchodilator is definitive of reversible airway disease.[1] Several conditions like sarcoidosis predominantly involve the interstitium have nevertheless been associated with reversible airways obstruction. Connective tissue diseases (CTDs) form another important subgroup of interstitial lung disease(ILD). CTDs usually produce a restrictive pattern of lung involvement on spirometry, but might have unrecognized additional reversible airway obstruction. Seeking out and treating the latter components of disease may be crucial in optimizing lung function and alleviating the breathlessness that is common to the problem. Aim: The aim of this study is therefore to determine the post bronchodilator response in patients with connective tissue disease related interstitial lung disease (CTD-ILD) and thus potentially help improve quality of life by addressing the latter component by inhaled bronchodilator-steroid therapy. Methods: Consecutive patients with a confirmed diagnosis of CTD-ILD were identified in the out-patient clinics of our institute. CTD was diagnosed by a combination of clinical and serological parameters. ILD was confirmed by high resolution computed tomography (HRCT) images.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Hasan_2021,

title = {Small airways, big problem: extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease- a systematic review},

author = {Ashfaq Hasan and Priyanka Mukherjee and Sushmeeta Chhowala and Meena Lopez and Prashant N. Chhajed},

url = {https://journals.lww.com/lungindia/Fulltext/2021/08000/Small_Airways,_Big_Problem__Extrafine.9.aspx},

doi = {10.4103/lungindia.lungindia_394_20},

issn = {0970-2113},

year  = {2021},

date = {2021-08-01},

urldate = {2021-08-01},

journal = {Lung India},

volume = {38},

issue = {4},

pages = {350-358},

abstract = {Asthma and chronic obstructive pulmonary disease (COPD) are common chronic respiratory diseases characterized by an inflammatory process that extends from the central to peripheral airways. Conventional pressurized metered-dose inhalers and most dry-powder inhalers emit drug particles too large to target the small airways effectively. Advancements in drug formulation have given rise to a new generation of inhalers that can generate aerosols with extrafine drug particles that leads to more effective aerosol penetration into the lung periphery. An extrafine formulation of inhaled beclomethasone/formoterol (BDP-FF) with enhanced lung deposition is now available. This document reviews the various real-world and controlled studies that have evaluated the efficacy of extrafine BDP-FF in asthma and COPD.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Afreen_2020b,

title = {Single nucleotide polymorphism in the promoter region of interleukin-4 and risk of asthma: TT homozygotes may have high propensity of developing chronic airway remodeling},

author = {Arshiya Afreen and S. Farhana F. A. and Sumaya Fatima and T. K. M. Rayees and Nida Makeen and Nusrath Fathima and Ashfaq Hasan and M. Aleemuddin Naveed and Fahad Abdullah Bin Breik and Mohd. Mohiuddin and Mohammed Ishaq},

url = {https://www.ijrrjournal.com/IJRR_Vol.7_Issue.9_Sep2020/IJRR0014.pdf},

issn = {2349-9788},

year  = {2020},

date = {2020-09-01},

urldate = {2020-09-01},

journal = {International Journal of Research and Review},

volume = {7},

issue = {9},

pages = {104-110},

abstract = {Background: In view of a key role played by Interleukin-4 (IL-4) in the molecular mechanisms leading to the development of asthma and its complications like chronic airway remodeling, a few reports have attempted to investigate a possible role of SNP’s in the promoter region to predict genetic risk. As it is associated with quantitative variations in IL-4 gene expression and may serve as an important candidate gene for asthma risk prediction. Objective: To investigate the polymorphic variations, at -590 (C/T) in the promoter region of IL-4 gene. Methods: 50 consecutively selected cases of asthma (36 females and 14 males) were recruited and genotyping for SNP at -590 C/T was done by PCR-RFLP method on the genomic DNA extracted from blood samples. Blood samples from 50 randomly selected healthy subjects served as controls. Mean values of Absolute Eosinophil Count and total serum IgE between the genotypes were compared by student’s unpaired t test. Odds-ratio analysis was carried out to determine risk of developing asthma. Results: Odds ratio (OR) analysis revealed two-and-a-half folds increased risk of asthma for individuals with TT genotype compared to those with CC genotype. A decreased frequency of CC genotype in patients (28%) compared to controls (58%) is indicative of protective nature of CC genotype. AEC counts and total serum IgE levels were significantly higher in TT compared to CC and CT genotypes. Conclusion: It is concluded that individuals with TT and CT genotypes (overproducers of IL-4) have high risk of developing asthma and high vulnerability to develop chronic airway remodeling.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Kerstgens_2020,

title = {IRIDIUM Trial. Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study},

author = {A. M. Kerstgens and Jorge Maspero and Kenneth R. Chapman and Richard N. van Zyl-Smit and Ashfaq Hasan and Syed Mahmood Ahmed and Fahad Abdullah Bin Breik},

url = {https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30190-9/fulltext},

doi = {10.1016/S2213-2600(20)30190-9},

issn = {2213-2600},

year  = {2020},

date = {2020-07-09},

urldate = {2020-07-09},

journal = {Lancet Respiratory Medicine},

volume = {8},

issue = {10},

pages = {1000-1012},

abstract = {Background: Patients with asthma who are inadequately controlled on inhaled corticosteroid–long-acting β2-adrenoceptor agonist (ICS–LABA) combinations might benefit from the addition of a long-acting muscarinic receptor antagonist. The aim of the IRIDIUM study was to assess the efficacy and safety of a once-daily, single-inhaler combination of mometasone furoate, indacaterol acetate, and glycopyrronium bromide (MF–IND–GLY) versus ICS–LABA in patients with inadequately controlled asthma. Methods: In this 52-week, double-blind, double-dummy, parallel-group, active-controlled phase 3 study, patients were recruited from 415 sites across 41 countries. Patients aged 18 to 75 years with symptomatic asthma despite treatment with medium-dose or high-dose ICS–LABA, at least one exacerbation in the previous year, and a percentage of predicted FEV1 of less than 80% were included. Enrolled patients were randomly assigned (1:1:1:1:1) via interactive response technology to receive medium-dose or high-dose MF–IND–GLY (80 μg, 150 μg, 50 μg; 160 μg, 150 μg, 50 μg) or MF–IND (160 μg, 150 μg; 320 μg, 150 μg) once daily via Breezhaler, or high-dose fluticasone–salmeterol (FLU–SAL; 500 μg, 50 μg) twice daily via Diskus. The primary outcome was change from baseline in trough FEV1 with MF–IND–GLY versus MF–IND at week 26 in patients in the full analysis set, analysed by means of a mixed model for repeated measures. Safety was assessed in all patients who received at least one dose of study drug. This study is registered with ClinicalTrials.gov, NCT02571777, and is completed. Findings: Between Dec 8, 2015, and Jun 14, 2019, 3092 of 4851 patients screened were randomly assigned (medium-dose MF–IND–GLY, n=620; high-dose MF–IND–GLY, n=619; medium-dose MF–IND, n=617; high-dose MF–IND, n=618; high-dose FLU–SAL, n=618). 2747 (88·8%) patients completed the 52-week treatment and 321 (10·4%) started but discontinued study treatment prematurely. Medium-dose MF–IND–GLY (treatment difference [Δ] 76 mL [95% CI 41–111]; p<0·001) and high-dose MF–IND–GLY (Δ 65 mL [31–99]; p<0·001) showed superior improvement in trough FEV1 versus corresponding doses of MF–IND at week 26. Improvements in trough FEV1 were greater for both medium-dose MF–IND–GLY (99 mL [64–133]; p<0·001) and high-dose MF–IND–GLY (119 mL [85–154]; p<0·001) than for high-dose FLU–SAL at week 26. Overall, the incidence of adverse events was balanced across the treatment groups. Seven deaths were reported (one with medium-dose MF–IND–GLY, two with high-dose MF–IND–GLY, and four with high-dose MF–IND) during the study; none of these deaths was considered by the investigators to be caused by study drugs or other study-related factors. Interpretation: Once-daily, single-inhaler MF–IND–GLY improved lung function versus ICS–LABA combinations (MF–IND and FLU–SAL) in patients with inadequately controlled asthma. The safety profile was similar across treatment groups. MF–IND–GLY therefore constitutes a good treatment option in these patients.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Nayar_2019,

title = {Management of community‐acquired bacterial pneumonia in adults: limitations of current antibiotics and future therapies},

author = {Sandeep Nayar and Ashfaq Hasan and Pradyut Waghray and Srinivasan Ramananthan and Jaishid Ahdal and Rishi Jain},

url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852216/pdf/LI-36-525.pdf},

doi = {10.4103/lungindia.lungindia_38_19},

issn = {0970-2113},

year  = {2019},

date = {2019-12-01},

urldate = {2019-12-01},

journal = {Lung India},

volume = {36},

issue = {6},

pages = {525-533},

abstract = {Community‑acquired bacterial pneumonia (CABP) is one of the leading causes of morbidity and mortality in India and worldwide. Evidence indicates that Gram‑positive, Gram‑negative, and atypical bacteria are encountered with near‑equal frequency. Despite guideline recommendations and antibiotic options for the management of CABP, burden of morbidity and mortality is high, which is attributable to a variety of factors. Failure of empirical therapy, probably because of insufficient microbial coverage, increasing bacterial resistance, and adverse effects of existing treatments, underlies the unsuccessful treatment of CABP, especially in India. Multiple novel therapies that have entered clinical development phases have potential to address some of these issues. This article discusses the current treatment guidelines in CABP, management limitations, and emerging potential treatment options in the management of CABP.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Dhar_2019,

title = {Bronchiectasis in India: results from the European multicentre bronchiectasis audit and research collaboration (EMBARC) and respiratory research network of India registry},

author = {Raja Dhar and Sheetu Singh and Deepak Talwar and Murali Mohan and Surya Kant Tripathi and M. Aleemuddin Naveed and Ashfaq Hasan},

url = {https://www.thelancet.com/action/showPdf?pii=S2214-109X%2819%2930327-4},

issn = {2214-109X},

year  = {2019},

date = {2019-09-01},

urldate = {2019-09-01},

journal = {Lancet Global Health},

volume = {7},

pages = {e1269-e1279},

abstract = {Background: Bronchiectasis is a common but neglected chronic lung disease. Most epidemiological data are limited to cohorts from Europe and the USA, with few data from low-income and middle-income countries. We therefore aimed to describe the characteristics, severity of disease, microbiology, and treatment of patients with bronchiectasis in India. Methods The Indian bronchiectasis registry is a multicentre, prospective, observational cohort study. Adult patients (≥18 years) with CT-confirmed bronchiectasis were enrolled from 31 centres across India. Patients with bronchiectasis due to cystic fibrosis or traction bronchiectasis associated with another respiratory disorder were excluded. Data were collected at baseline (recruitment) with follow-up visits taking place once per year. Comprehensive clinical data were collected through the European Multicentre Bronchiectasis Audit and Research Collaboration registry platform. Underlying aetiology of bronchiectasis, as well as treatment and risk factors for bronchiectasis were analysed in the Indian bronchiectasis registry. Comparisons of demographics were made with published European and US registries, and quality of care was benchmarked against the 2017 European Respiratory Society guidelines. Findings: From June 1, 2015, to Sept 1, 2017, 2195 patients were enrolled. Marked differences were observed between

India, Europe, and the USA. Patients in India were younger (median age 56 years [IQR 41–66] vs the European and

US registries; p<0∙0001]) and more likely to be men (1249 [56∙9%] of 2195). Previous tuberculosis (780 [35∙5%] of

2195) was the most frequent underlying cause of bronchiectasis and Pseudomonas aeruginosa was the most common

organism in sputum culture (301 [13∙7%]) in India. Risk factors for exacerbations included being of the male sex

(adjusted incidence rate ratio 1∙17, 95% CI 1∙03–1∙32; p=0∙015), P aeruginosa infection (1∙29, 1∙10–1∙50; p=0∙001), a

history of pulmonary tuberculosis (1∙20, 1∙07–1∙34; p=0∙002), modified Medical Research Council Dyspnoea score

(1∙32, 1∙25–1∙39; p<0∙0001), daily sputum production (1∙16, 1∙03–1∙30; p=0∙013), and radiological severity of disease

(1∙03, 1∙01–1∙04; p<0∙0001). Low adherence to guideline-recommended care was observed; only 388 patients were

tested for allergic bronchopulmonary aspergillosis and 82 patients had been tested for immunoglobulins.

Interpretation Patients with bronchiectasis in India have more severe disease and have distinct characteristics from

those reported in other countries. This study provides a benchmark to improve quality of care for patients with

bronchiectasis in India.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Uzma_2019,

title = {Assessment of neurocognitive impairment in obstructive sleep apnea},

author = {Nazia Uzma and Juhi Fatima Sultan and Nooruddin Owaisi and Mariya Syed and Abid Ali Khan and Ashfaq Hasan},

url = {https://ijop.net/index.php/ijop/article/view/217},

doi = {10.37506/ijop.v7i2.217},

issn = {2320-6039},

year  = {2019},

date = {2019-07-20},

urldate = {2019-07-01},

journal = {International Journal of Physiology},

volume = {7},

issue = {2},

pages = {126-130},

abstract = {Sleep apnea is usually reported in south Indian population. The indications of obstructive sleep apnea (OSA) comprise of breathing difficulties particularly owing to obstruction in the upper airway tract. The present study investigated the effect of the syndrome, the patients documented with OSA, by categorizing the patients into mild, moderate and severe OSA groups depending on apnea-hyponea index (AHI), derived from sleep study (polysomnographic findings). The comparative evaluation of various outcomes considered in this study included healthy individuals (control group, AHI < 5), mild OSA (AHI 5–15), moderate (OSA 15–30) and severe (AHI > 30). Investigations were conducted on the subjects which evaluated baseline characteristics, polysomnographic data and neuro-cognitive performances by Mini-Mental State Examination (MMSE). The results revealed significantly higher body mass index (BMI), snoring and decresed sleep efficiency in patients with sleep apnea syndrome when compared with control group. OSA patients further exhibited compromised neuro-cognitive. The intensity of the impairments and difficulties increased with upsurge in severity of the syndrome among all patients. The findings of this work strongly indicated that impaired executive functioning; neuro-cognitive abnormalities exit in a heightened state among OSA patients, than in the normal healthy individuals, the control group. These findings in aggregate would help clinicians in diagnosis and in understanding the disease prognosis.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Jameel_2019,

title = {Prevention of complications in Type II diabetes mellitus by measuring glycated hemoglobin, 24 hours urinary protein and protein creatinine ratio and fundus examination},

author = {Tahmeen Jameel and Syed Mahmood Ahmed and Aiman Mahmood and Mahbub Unnisa},

url = {https://www.iosrjournals.org/iosr-jbb/papers/Volume%205,%20Issue%204/C0504012022.pdf},

doi = {10.9790/264X-0504012022},

issn = {2455-264X},

year  = {2019},

date = {2019-07-16},

urldate = {2019-07-16},

journal = {IOSR Journal of Biotechnology and Biochemistry},

volume = {5},

issue = {4},

pages = {20-22},

abstract = {The measurement of glycated hemoglobin, 24 hours urinary protein and protein creatinine ratio serves as an important index in the monitoring of diabetes patients to prevent the complications. Screening patients for Retinopathy is again very important. The cause of diabetic complication is not known. Major emphasis has been placed on the polyol pathway where in glucose is reduced to sorbitol by the enzyme aldolase reductase with reduced NADPH as the electron donating coenzyme. Sorbitol molecule is oxidized to fructose by the enzyme Sorbitol dehydrogenase and reduced NAD+ . Sorbitol appears to function as a tissue toxin and has been implicated in the pathogenicity of retinopathy, neuropathy and cataract. Among the clinically important secondary microvascular complications of diabetes, kidney as the target organ represents a health problem of enormous social cost. Nephropathy like other diabetic complications is probably influenced by genetic factors. 35% of NIDDM patients develop nephropathy. Diabetic nephropathy is duration dependent and extends over many years before becoming clinically evident. Persistent proteinuria appears to predict evidence of kidney damage. Proteinuria is the most widely accepted sign of diabetic nephropathy. Spot protein, creatinine ratio would be more accurate and less time consuming. Diabetic nephropathy is leading cause of morbidity and premature mortality in diabetes subjects. Diabetic nephropathy has an insidious onset with increase in glycated hemoglobin before the appearance of microalbuminuria.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Kilaru_2019,

title = {Active pulmonary tuberculosis presenting with acute respiratory failure},

author = {Satish Chandra Kilaru and Sudhir Prasad and Hemanth Kilaru and Raghavender Reddy Anneela and Ashfaq Hasan and Eshwar Chandra Nandury},

url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635142/pdf/RCR2-7-e00460.pdf},

doi = {10.1002/rcr2.460},

issn = {2051-3380},

year  = {2019},

date = {2019-07-16},

urldate = {2019-07-16},

journal = {Respiratory Case Reports},

volume = {7},

issue = {7},

pages = {1-5},

abstract = {Four patients with active pulmonary tuberculosis (PTB) presenting with respiratory failure are reported here. Bronchogenic PTB, simulating an acute febrile illness or diffuse interstitial lung disease with short duration of

symptoms, as a cause of acute respiratory failure is less recognized. If diagnosed and treated early, it has good prognosis. Three of the four patients presented here had an acute presentation with fever, dyspnoea, and hypoxemia with diffuse infiltrative lesions on radiography, and the other younger patient presented predominantly with lobar consolidation. These patients presenting with respiratory failure required intensive care management, and a diagnosis was made with bronchoalveolar lavage fluid and transbronchial lung biopsy. All four patients promptly received antitubercular therapy, showed clinicoradiological improvement, and were stable at 1 year follow up. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Tirunagari_2018,

title = { Koch’s with Kikuchi together in a young male},

author = {L. N. Swamy Tirunagari and Ashfaq Hasan},

url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120309/pdf/LI-35-443.pdf},

doi = {10.4103/lungindia.lungindia_422_17},

issn = {0970-2113},

year  = {2018},

date = {2018-10-01},

urldate = {2018-10-01},

journal = {Lung India},

volume = {35},

issue = {5},

pages = {443-444},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Naveed_2018,

title = {N-acetylcysteine in a treatment of COPD},

author = {M. Aleemuddin Naveed and Raheem Fatima and Mohammed Mohsin and Ashfaq Hasan},

url = {https://www.ijirm.org/journal-article-file/7457},

doi = {10.18231/2581-4222.2018.0035},

issn = {2581-4214},

year  = {2018},

date = {2018-09-01},

urldate = {2018-09-01},

journal = {IP Indian Journal of Immunology and Respiratory Medicine},

volume = {3},

issue = {3},

pages = {137-146},

abstract = {Introduction: In COPD excess expectoration secondary to tracheobronchial secretions contributes to symptoms, airflow obstruction and is diagnostic criterion. It also causes increased mortality, risk of hospitalizations and accelerated decline in FEV1. N-acetylcysteine (NAC) helps in liquefying mucus and DNA (via disruption of disulfide bonds) and has antioxidant effects. Aims: Evaluate add-on effect of NAC on clinical-physiological parameters in COPD patients treated according to GOLD guidelines. Material and Methods: Single labeled, randomized, parallel group prospective Observational study. In 120 stable COPD patients Modified medical research council (MMRC) dyspnoea score, COPD Assessment test (CAT score), number of exacerbations and hospitalizations in the last year were recorded and were randomized into 2 groups of 60 each. Group A

received NAC 600mg twice daily along with standard treatment. Group B received standard treatment only. Mean and Standard Deviation was compared between groups using unpaired t-test. After 1 year, changes in above parameters were reassessed. Statistical Analysis: Unpaired t-test and chi square test were used. Statistical significance was set at <0.05 level. Results: MMRC score reduced from 3.37 study group) to 2.91, difference being -0.46, and in control from 3.37 to 1.18, difference of -0.22 and p value of p<.05. CAT score reduced more in test group (-4.4) than control group (-3.1), p=.02. Out of 40 exacerbations, 14 (35%) occurred in test and 26 (65%) in control group, reduction of 30% and p=0.01. Out of 28 hospitalizations 10 (36%) test group 18 (64%) control group. i.e. a reduction of 28% and p=0.06. Conclusions: Use of N-Acetyl Cysteine, 600mg twice daily along with standard treatment can bring clinically significant change in CAT Score and frequency of exacerbations but not in MMRC score and hospitalizations. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Breik_2017,

title = {Carina at the carina: spirometry leading to the diagnosis of an unusual foreign body within the tracheobronchial tree},

author = {Fahad Abdullah Bin Breik and Ghouse Ahmed Khan and Sandeep Saboo and Raheem Hussain and Ashfaq Hasan},

url = {https://www.respircase.com/jvi.aspx?un=RCR-61587&volume=6&issue=1},

doi = {10.5505/respircase.2017.61587},

issn = {2051-3380},

year  = {2017},

date = {2017-02-28},

journal = {Respiratory Case Reports},

volume = {6},

issue = {1},

pages = {1-4},

abstract = {Foreign bodies in the lung can be difficult to diagnose. They may result in unusual symptoms leading to confusion about the diagnosis. Spirometry can sometimes provide a clue to a mainstem obstruction, although it may be compromised by artifacts. Herein, we present a case of an unusual foreign body within the tracheobronchial tree, for which spirometry provided the indication for bronchoscopy.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Hasan_2017b,

title = {Noughts and crosses: the uncertain future of TB control in India},

author = {Ashfaq Hasan},

url = {https://jmas.in/fulltext/154-1485322681.pdf?1676958653},

doi = {10.5455/jmas.256739 },

issn = {2231-1696},

year  = {2017},

date = {2017-01-31},

urldate = {2017-01-31},

journal = {Journal of Medical and Allied Sciences},

volume = {7},

issue = {1},

pages = {1-2},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Hasan_2017,

title = {Is obstructive sleep apnea more prevalent than central sleep apnea in patients with systolic heart failure? A retrospective study},

author = {Ashfaq Hasan and Nazia Uzma and Fahad Abdullah Bin Breik and Mohammed Abdul Hannan Hazari and C. Narasimhan and L. Rao},

url = {https://www.hilarispublisher.com/archive/jcrdc-volume-3-issue-1-year-2017.html},

doi = {10.4172/2472-1247.1000126},

year  = {2017},

date = {2017-01-01},

urldate = {2017-01-01},

journal = {Journal of Clinical Respiratory Diseases and Care},

volume = {03},

issue = {01},

pages = {126},

publisher = {OMICS Publishing Group},

abstract = {Central sleep apnea (CSA) rather than obstructive sleep apnea (OSA) is widely believed to be the dominant form of sleep apnea (SA) in patients with heart failure (HF). Hitherto, no study has characterized sleep disordered breathing (SDB) in Indian subjects with heart failure and evaluated its impact on severity of HF, which this study attempts to do. A retrospective data-analysis was done in 65 consecutive patients with stable mild-to-moderate HF referred for evaluation on the basis of fatigue and excessive daytime somnolence (EDS) regarded by the institute’s cardiologists. Patients with ejection fraction (EF) <55% or LV fractional shortening of 28% were included in the study. PSG was scored according to current AASM recommendations. Based on the Apnea-Hypopnea Index (AHI), OSA was classified as mild (AHI:5-15), moderate (AHI: 15-30) and severe (AHI: >30). HF was arbitrarily classified as mild (EF:<35%) moderate (EF:35-45%) and severe (EF:45-55%). OSA emerged as the exclusive form of SA (95.4%; n=65) and was more severe in males. Patients with more severe HF tended to be less obese, and interestingly to have less severe OSA. In contrast to Western literature, OSA seems to be by far the most prevalent form of sleep apnea in Indian subjects with HF. HF mortality is known to be high in underweight individuals yet, persons with severe HF are often less obese and partly by reason of a lower BMI, appear to be relatively protected against severe OSA and severe nocturnal hypoxemia. This study thus raises important and intriguing questions which merit further enquiry.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Mathai_2016,

title = {Consensus recommendation for India and Bangladesh for the use of pneumococcal vaccine in mass gatherings with special reference to hajj pilgrims},

author = {Dilip Mathai and Abul Khair Mohammad Shamsuzzaman and Ahrar Ahmed Feroz and Amin R. Virani and Ashfaq Hasan and K. L. Ravi Kumar and Khalid Ansari},

url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126751/pdf/JGID-8-129.pdf},

doi = {10.4103/0974-777X.193749},

issn = {0974-777X},

year  = {2016},

date = {2016-12-01},

urldate = {2016-12-01},

journal = {Journal of Global Infectious Diseases},

volume = {8},

pages = {129-138},

abstract = {Respiratory tract infections are prevalent among Hajj pilgrims with pneumonia being a leading cause of hospitalization. Streptococcus pneumoniae is a common pathogen isolated from patients with pneumonia and respiratory tract infections during Hajj. There is a significant burden of pneumococcal disease in India, which can be prevented. Guidelines for preventive measures and adult immunization have been published in India, but the implementation of the guidelines is low. Data from Bangladesh are available about significant mortality due to respiratory infections; however, literature regarding guidelines for adult immunization is limited. There is a need for extensive awareness programs across India and Bangladesh. Hence, there was a general consensus about the necessity for a rapid and urgent implementation of measures to prevent respiratory infections in pilgrims traveling to Hajj. About ten countries have developed recommendations for pneumococcal vaccination in Hajj pilgrims: France, the USA, Kuwait, Qatar, Bahrain, the UAE(Dubai Health Authority), Singapore, Malaysia, Egypt, and Indonesia. At any given point whether it is Hajj or Umrah, more than a million people are present in the holy places of Mecca and Madina. Therefore, the preventive measures taken for Hajj apply for Umrah as well. This document puts forward the consensus recommendations by a group of twenty doctors following a closed-door discussion based on the scientific evidence available for India and Bangladesh regarding the prevention of respiratory tract infections in Hajj pilgrims. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Khan_2016c,

title = {Rifampicin-induced interstitial nephritis: a case report and a short review of the literature},

author = {Ghouse Ahmed Khan and Fahad Abdullah Bin Breik and Yaseen Mohiuddin and S. V. Parathasaradhy and Mazharuddin Ali Khan and Ashfaq Hasan},

url = {https://jmas.in/fulltext/154-1463412038.pdf?1676966897},

doi = {10.5455/jmas.229206},

issn = {2231-1696},

year  = {2016},

date = {2016-07-31},

urldate = {2016-07-31},

journal = {Journal of Medical and Allied Sciences},

volume = {6},

issue = {2},

pages = {84-86},

abstract = {Rifampicin induced acute interstitial nephritis (AIN) is a relatively rare entity, but in a setting of high tuberculosis (TB) prevalence, may be met with on occasion. TB is rife. If diagnosed and treated in time, the prognosis for renal recovery is good. We present such a case of a 42 year old woman who developed ATN after treatment with a rifampicin-based anti-tubercular regimen for TB synovitis of the wrist, nevertheless patient recovered after steriod therapy.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Bardia_2016,

title = {Genetic polymorphisms of X-ray repair cross-complementing group 1 and Apurinic/Apyrimidinic endonuclease-1 in chronic obstructive pulmonary disease},

author = {Avinash Bardia and Sandeep Kumar Vishwakarma and Chandrakala Lakki Reddy and N. Raju and Shaik Iqbal and Gallapalli Sravani and Narneni Lavanya and Nazima Begum and Nazia Uzma and Pratibha Nallari and Badruz Zama and Syed Mahmood Ahmed and Ashfaq Hasan and Aleem Ahmed Khan},

url = {https://link.springer.com/article/10.1007/s10753-016-0355-x},

doi = {10.1007/s10753-016-0355-x},

issn = {0360-3997},

year  = {2016},

date = {2016-04-23},

urldate = {2016-04-23},

journal = {Inflammation},

volume = {39},

issue = {3},

pages = {1198–1204},

abstract = {Chronic obstructive pulmonary disease (COPD) is a heterogeneous collection of conditions characterized by irreversible expiratory airflow limitation. The disease is interspersed with exacerbations; periods of acute symptomatic, physiological, and functional deterioration. The present study was designed to investigate the role of X-ray cross-complementing group 1 (XRCC1) and apurinic/apyrimidinic endonuclease 1 (APE1) polymorphisms and the risk of COPD. Blood samples from 354 unrelated subject (age range 18–60 years; 156 with COPD, 198 healthy controls) were collected. Genomic DNA was isolated and genotyped for XRCC1 Arg399Gln and APE1 Asp148Glu using a confronting two pair primers polymerase chain reaction. GA genotype of XRCC1 gene was found to be predominant in the COPD group compared to controls with 1.86-fold increased risk for COPD (OR 1.86, 95 % CI 1.20–2.88, p = 0.0013). TG genotype of APE1 was found to be predominant in COPD group compared to controls with the difference being statistically significant (OR 1.68, 95 % CI 1.08–2.61, p = 0.0043). The GA haplotype was found to be predominant in COPD than controls with a 2.19-fold significant increase (OR 2.19, 95 % CI 1.46–3.28, p = 0.003). Polymorphism in XRCC1 and APE1 gene is associated with an increased risk of COPD.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Uzma_2015,

title = {Epidemiology, clinical profiles and risk factors in obstructive sleep apnea},

author = {Nazia Uzma and Ashfaq Hasan and Bhaskarpillai Santhosh Kumar and Hamid Abdul Qaiyum and Doddamani R. Basalingappa and Vontela Devender Reddy},

url = {https://www.minervamedica.it/en/journals/minerva-respiratory-medicine/article.php?cod=R16Y2015N04A0161#},

issn = {2724-6493},

year  = {2015},

date = {2015-12-31},

journal = {Minerva Pneumologica},

volume = {54},

issue = {4},

pages = {161-168},

publisher = {Edizioni Minerva Medica},

abstract = {Obstructive sleep apnea (OSA) is a common medical condition with significant adverse effects but it remains undiagnosed in many individuals. The present hospital based study assessed the prevalence, related clinical features and risk factors of OSA in the South Indian population. One ninety two untreated OSA patients and sixty two control subjects were included in this study. Each subject underwent a fully attended polysomnogram (PSG), spirometric analysis, modified OSA questionnaires and Mallampati score were obtained in study population. The OSA patients were divided into three subgroups: mild (29%), moderate (15%) and severe (56%) and the mean±SD of Apnea-Hypopnea Index (AHI) was 11.4±3, 24.8±5.1 and 36.6±7.4 respectively. Higher Mallampati score was observed in patients with severe OSA than in moderate and mild OSA patients. An apparent decrease in FVC and FEV1 was observed in OSA group with a positive correlation with increase in AHI. A significant decrease in FVC, FEV1 and FEV1/FVC was observed with increase in Body Mass Index (BMI), reflecting the increased restrictive pattern in the OSA groups. Sleep onset latency was increased to 18.6±13.2 than 8.8±3.2 with a sleep efficiency of 74.2±4.8 and 90.2% in OSA group and controls respectively. The apnea index, hypopnea index and microarousals were much higher in the OSA groups than in controls. Statistically significant differences were perceived in the fasting blood glucose levels, triglyceride, LDL, HDL and total cholesterol levels between the OSA group and controls. This study adds evidence for a link between the clinical features, epidemiology and risk factors of OSA.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Hasan_2015,

title = {The singular case of the pleural effusion},

author = {Ashfaq Hasan},

url = {https://jmas.in/fulltext/154-1449159001.pdf?1676967274},

issn = {2231-1696},

year  = {2015},

date = {2015-12-01},

urldate = {2015-12-01},

journal = {Journal of Medical and Allied Sciences},

volume = {5},

issue = {2},

pages = {24-25},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{pmid26229751,

title = {Cost-effectiveness analysis of three different combinations of inhalers for severe and very severe chronic obstructive pulmonary disease patients at a tertiary care teaching hospital of South India},

author = {Mohammed Altaf and Ayesha Mubeen Zubedi and Fareesa Nazneen and Shaik Kareemulla and Syed Amir Ali and Mirza Misba Ali Baig and M. Aleemuddin Naveed and Mohammed Abdul Hannan Hazari},

url = {https://journals.lww.com/picp/Fulltext/2015/06030/Cost_effectiveness_analysis_of_three_different.7.aspx},

doi = {10.4103/2229-3485.159940},

issn = {2229-3485},

year  = {2015},

date = {2015-09-30},

urldate = {2015-09-30},

journal = {Perspectives in Clinical Research},

volume = {6},

issue = {3},

pages = {150-158},

publisher = {Wolters Kluwer - Medknow},

crossref = {Altaf_2015},

abstract = {Background: This study aims at simplifying the practical patient management and offers some general indications for pharmacotherapeutic choice by the implementation of (Global Initiative for Chronic Lung Disease) guidelines. This study was designed to evaluate the clinical and economic consequences of salmeterol/fluticasone (SF), formoterol/budesonide (FB), and formoterol/fluticasone (FF) in severe and very severe chronic obstructive pulmonary disease (COPD) patients.

Objectives: The aim was to find out the most cost-effective drug combination between the three combinations (SF/FB/FF) in COPD patients.

Materials and Methods: A prospective observational comparative study (cost-effectiveness analysis), in which 90 severe (30 ≤ forced expiratory volume in 1 s [FEV1] <50% predicted) and very severe (FEV1 < 30% predicted) COPD patients (outpatients/inpatients) who are prescribed with any one of the following combinations (SF/FB/FF) were selected. In our study, we have divided 90 COPD patients into three groups (Group I, Group II, and Group III) each group consisting of 30 patients. Group I was prescribed with medication SF, Group II with medication FB, and Group III with medication FF. We used five different parameters such as spirometry test (mean FEV1 initial and final visit), number of symptom-free days (SFDs), number of moderate and severe exacerbations, Number of days of hospitalization and direct, indirect, and total cost to assess the cost-effectiveness of SF/FB/FF. Comparison of cost and effects was done during the period of 6 months of using SF/FB/FF.

Results: The average FEV1 for Group I, Group II, and Group III subjects at initial visit was 33.47%, 33.73%, and 33.20% and was increased to 36.60%, 35.8%, and 33.4%, respectively. A 3% increment in FEV1 was reported for Group I subjects (SF) and was highly significant statistically (t = −8.833, P = 0.000) at 95% CI. For Group II subjects (FB), a 2% increment in FEV1 was reported and was highly significant statistically (t = −9.001, P = 0.000) at 95% CI. For Group III (FF) subjects 0.2% increment in FEV1. The overall mean total cost for Group I, Group II, and Group III subjects during the 6 months period was found to be Rs. 29,725/-, Rs. 32,602/- and Rs. 37,155/-. Incremental cost-effectiveness of FB versus SF was Rs. 37,781/- per avoided exacerbation and Rs. 661/-per SFD.

Conclusion: This study highlights the favorable therapeutic performance of combined inhaled bronchodilators and corticosteroids (SF/FB/FF), thus suggesting that healthcare costs would be also affected positively. Results from our study showed that SF and FB were the most effective strategies in the treatment of COPD, with a slight clinical superiority of SF. The FF strategy was not much effective (i.e. associated with fewer outcomes and higher costs).},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Hasan_2015b,

title = {Pneumococcal disease: closing the gap},

author = {Ashfaq Hasan},

url = {https://jmas.in/fulltext/154-1451027383.pdf?1676968952},

issn = {2231-1696},

year  = {2015},

date = {2015-06-30},

urldate = {2015-06-30},

journal = {Journal of Medical and Allied Sciences},

volume = {5},

issue = {1},

pages = {1},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Khan_2014b,

title = {Cardiovascular collapse following intramyometrial injection of prostaglandin},

author = {Basheer Ahmed Khan and Vijaya Rekha Koti and Murtuza Khan and Syed Asrar Hussain and Mohammed Mohib Hussain and M. Aleemuddin Naveed},

url = {http://www.jcmad.com/admin/pdf/239a17.pdf},

doi = {10.18049/jcmad/239a17},

issn = {2347-4513},

year  = {2014},

date = {2014-12-31},

urldate = {2014-12-31},

journal = {Journal of Contemporary Medicine and Dentistry},

volume = {2},

issue = {3},

pages = {80-82},

abstract = {A 21 year old female gravida 2, para 1, live 1 with previous lower segment cesaerian section (LSCS), hypothyroid on tablet Eltroxin 12.5mcg, was posted for LSCS. Spinal anaesthesia was given and the effect was patchy, hence general anaesthesia was supplemented. Intramyometrial prostaglandin was given by surgeon for persisting uterine atony following which patient developed hypertension, tachycardia, pulmonary edema and later on cardiac arrest.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Maaz_2014,

title = {Training in the use of inhalation devices and respiratory improvement in asthma and COPD patients: A before-after experimental study},

author = {Mohammed Maazuddin and Mohammed Abdul Hannan Hazari and Ashfaq Hasan and Mohd. Javeedullah and Mohd. Nasir Mohiuddin and Mirza Misba Ali Baig},

url = {https://www.researchgate.net/publication/272944333_Training_in_the_use_of_inhalation_devices_and_respiratory_improvement_in_asthma_and_COPD_patients_A_before-after_experimental_study},

issn = {2231-0541},

year  = {2014},

date = {2014-11-01},

journal = {PHARMANEST},

volume = {5},

issue = {5},

pages = {2314-2320},

abstract = {Objective: The aim of the study was to assess the effectiveness of one-time personalized intervention by pharmacists in the form of training in correct inhaler technique. Methods: 104 asthma and COPD patients attending the out-patient department Pulmonary Medicine of a medical college hospital in Hyderabad were recruited for the study. At two different visits, patients were assessed for their respiratory status, importance of treatment and inhaler technique. After assessment at the first visit, patients were given one-time health education about the disease and the correct inhaler technique was demonstrated by hospital based pharmacists. Comparisons were made between the two visits for respiratory status using St. George’s Respiratory Questionnaire. We used students‘t’ test for comparing the results. Results: There was reduction in SGRQ scores irrespective of the device used which shows the effectiveness of one-time health education and training. The changes in SGRQ scores were found to be statistically significant with all devices except with use of Rotahaler and Starhaler. Conclusion: Inhalation technique of patients is usually poor regardless of the device prescribed, and educational intervention with the demonstration of the sequential steps involved in particular inhaler results in significant improvement in inhalational technique. Intervention by hospital based pharmacists proved more effective than the verbal instructions given in the physician’s consultation room. Therefore, sufficient time should be devoted for a practical demonstration of inhaler technique after prescribing.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Altaf_2014,

title = {Cost-effectiveness analysis of combined inhaled corticosteroids and bronchodilators for severe and very severe COPD patients in a teaching hospital},

author = {Mohammed Altaf and Ayesha Mubeen Zubedi and Fareesa Nazneen and Shaik Kareemulla and Syed Amir Ali and Mirza Misba Ali Baig and Arshad Hussain Mohd and M. Aleemuddin Naveed and Mohammed Abdul Hannan Hazari and Syed Abdul Azeez},

url = {http://iosrphr.org/papers/v4i06/Part_2/C04602012023.pdf},

doi = {10.9790/3013-040602012023},

issn = {2250-3013},

year  = {2014},

date = {2014-06-30},

urldate = {2014-01-01},

journal = {IOSR Journal of Pharmacy (IOSRPHR)},

volume = {4},

issue = {6},

pages = {12-23},

publisher = {IOSR Journals},

crossref = {Altaf_2014},

abstract = {BACKGROUND: This study aims at simplifying the practical patient management and offers some general indications for pharmacotherapeutic choice by the implementation of (GOLD 2004) guidelines. This study was designed to evaluate the clinical and economic consequences of Salmeterol/Fluticasone(SF), Formoterol/Budesonide(FB) and Formoterol/Fluticasone(FF) in severe and very severe COPD patients. 

OBJECTIVES: To find out the most cost-effective drug combination between the three combinations (SF/FB/FF) in COPD patients. 

METHODS: A Prospective observational Comparative study (Cost-effectiveness Analysis) in which 90 severe (30≤FEV1<50% predicted) and very severe (FEV1<30% predicted) COPD patients (OP/IP) who are prescribed with any one of the following combinations (SF/FB/FF) were selected. In our study we have divided 90 COPD patients into 3 groups (Group I, Group II & Group III) each group consisting of 30 patients. Group I was prescribed with medication SF (salmeterol/fluticasone), Group II with medication FB (formoterol/budesonide) and Group III with medication FF (formoterol/fluticasone). We used five different parameters such as Spirometry test (mean FEV1 initial & final visit), Number of symptom free days, Number of moderate & severe exacerbations and Direct, indirect & total cost to assess the cost-effectiveness of SF/FB/FF. Comparison of cost and effects was done during the period of 6 months of using SF/FB/FF. RESULTS: The average FEV1 for group I, group II and group III subjects at initial visit was 33.47%, 33.73% & 33.20% and was increased to 36.60%, 35.8% and 33.4% respectively. A 3% increment in FEV1 was reported for group I subjects (SF) and was highly significant statistically (t=-8.833},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Naveed_2014,

title = {A cross-sectional study on prescribing patterns on patients suffering from respiratory disorders in a teaching hospital of South India},

author = {M. Aleemuddin Naveed and Farah Bahmed and Mohammed Shakeel Mohammed Bashir and Syed Amir Ali and Salma Khatoon and Md. Mohib Hussain and Afshan Khatoon},

doi = {10.18049/jcmad/213},

issn = {2347-4513},

year  = {2014},

date = {2014-04-30},

urldate = {2014-04-30},

journal = {Journal of Contemporary Medicine and Dentistry},

volume = {2},

issue = {1},

pages = {12-17},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Jameel_2014,

title = {Estimation of glycated hemoglobin in Type 2 diabetes mellitus},

author = {Tahmeen Jameel and Syed Mahmood Ahmed },

url = {https://www.cibtech.org/J-Innovative-Research-Review/Publications/2014/Vol-2-No-1/JIRR-05-010-TAHMEEN-ESTIMATION-MELLITUS.pdf},

issn = {2347-4424},

year  = {2014},

date = {2014-01-01},

urldate = {2014-01-01},

journal = {International Journal of Innovative Research and Review},

volume = {2},

issue = {1},

pages = {29-34},

abstract = {The study on measurement of glycated haemoglobin levels serves as an important index in the diagnosis of diabetes and also monitoring of diabetes patients to prevent the complications. The cause of diabetic complication is not known. Major emphasis has been placed on the polyol pathway where in glucose is reduced to sorbitol by the enzyme aldose reductase with reduced NADPH as the electron donating coenzyme. Sorbitol molecule is oxidised to fructose by the enzyme sorbitol dehydrogenase and reduced NAD+. Sorbitol appears to function as a tissue toxin and has been implicated in pathogenesis of retinopathy, neuropathy, cataract and aortic diseases. A second mechanism of potential pathogenetic importance is glycation of proteins. Glycation is non enzymatic addition of hexoses to proteins and glycosylation is enzymatic addition. This chemical reaction is the linkage between a reducing sugar and a receptive amino acid. It was first described in relation to food proteins (Millard, 1913). It has been shown that the difference in ionic charge between HBA1c and ordinary adult haemoglobin was due to addition of a glucose molecule to the amino terminal valine of the beta chain via an aldimine linkage which then underwent an Amadori rearrangement to form a more stable and virtually irreversible ketamine product (Bookchin, 1968; Bunn, 1975). The logical culmination of these findings was the hypothesis that in diabetes the level of glycosylated haemoglobin HBA1c or HBA1 would be proportional to the time averaged blood glucose level in the previous 7-8weeks, a period approximating to the half life of the average red blood cells. Normal glucose produces a normal amount of glycated haemoglobin. In diabetes mellitus higher amount of glycated haemoglobin indicates poorer control of blood glucose level. Fasting plasma glucose and glycated haemoglobin was estimated and based on the results the subjects were classified into three groups. Group I: Normal control non diabetic subjects; Group II: DM with good glycaemic control; Group III: DM with poor glycaemic control; Group II and group III patients were evaluated for complications by including lipid profile, tests for protein in urine and fundus examination. It was found that one or more complications were more predominant in Group III than in group II subjects. },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Jameel_2013,

title = {Estimation of lecithin cholesterol acyl transferase activity and high density lipoprotein cholesterol in type 2 diabetes mellitus},

author = {Tahmeen Jameel and Syed Mahmood Ahmed },

url = {https://www.cibtech.org/J-MEDICAL-SCIENCES/PUBLICATIONS/2013/Vol_3_No_3/JMS-14-022-TAHMEEN-%20ESTIMATION-%20MELLITUS.pdf},

issn = {2277-2103},

year  = {2013},

date = {2013-01-01},

urldate = {2013-01-01},

journal = {International Journal of Basic and Applied Medical Sciences},

volume = {3},

issue = {3},

pages = {100-109},

abstract = {An important enzyme in modulating plasma HDL levels is lecithin cholesterol acyl transferase (LCAT) which is responsible for the formation of most of the cholesterol esters (CE) present in human plasma. This enzyme catalyses the transfer of fatty acid from the Sn-2 position of the lecithin to the free hydroxyl group of cholesterol. It utilizes linoleate for the esterification of cholesterol in preference to the other fatty acids. Thus the enrichment of the linoleate content of plasma lecithin which accompanies ingestion of a poly unsaturated fat diet leads to an increase in the proportion of cholesterol linoleate in plasma. The physiological substrate for LCAT is probably nascent HDL. The enzyme activity is dependent on apoA-1 and is inhibited by apoA-2. Thus the maturing HDL particles contain mainly esterified cholesterol which having been rendered non diffusible are trapped in the HDL and then are transferred to the liver to undergo catabolism. Present studies have been carried out on diabetic patients with good glycaemic control and diabetics with poor glycaemic control and compared with normal control group. HDL cholesterol levels in diabetic patients with good and poor glycaemic control were significantly lower than the normal control group. LCAT in diabetic patients with good and poor glycaemic control were significantly lower than the normal control group. However HDL cholesterol level and LCAT activity in diabetic patients with poor glycaemic control was still lower this supports the observation that coronary artery disease (CAD) is 2-4 times higher in diabetes than in non diabetes.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Jameel_2013b,

title = {Estimation of lipid profile in type 2 diabetes mellitus},

author = {Tahmeen Jameel and Raisa Faheem and Syed Mahmood Ahmed},

url = {https://www.cibtech.org/J-MEDICAL-SCIENCES/PUBLICATIONS/2013/Vol_3_No_3/JMS-05-006-%20TAHMEEN-%20ESTIMATION-%20MELLITUS.pdf},

issn = {2277-2103},

year  = {2013},

date = {2013-01-01},

urldate = {2013-01-01},

journal = {International Journal of Basic and Applied Medical Sciences},

volume = {3},

issue = {3},

pages = {24-38},

abstract = {Impaired Lipid Metabolism resulting from uncontrolled hyperglycemia has been implicated in cardiovascular complications in diabetes patients. In the present study the impact of glycaemic control on the lipid profile of diabetic patients is examined. Lipoprotein levels are measured in non-diabetic persons and NIDDM (Type 2 DM) patients with good control and poor control of Diabetes mellitus (DM). The present study also reveals that reducing LDL cholesterol is beneficial in reducing CAD risk and lowering of LDL cholesterol being a primary target in the prevention of CAD.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Hasan_2012,

title = {Correlation of clinical profiles with obstructive sleep apnea and metabolic syndrome},

author = {Ashfaq Hasan and Nazia Uzma and L. N. Swamy Tirunagari and Alluri Shoba and Bhaskarpillai Santhosh Kumar},

url = {https://link.springer.com/article/10.1007/s11325-010-0463-z},

doi = {10.1007/s11325-010-0463-z},

issn = {1520-9512},

year  = {2012},

date = {2012-03-01},

urldate = {2012-03-01},

journal = {Sleep and Breathing},

volume = {16},

issue = {1},

pages = {111-116},

publisher = {Springer Science and Business Media LLC},

abstract = {Background: Obstructive sleep apnea (OSA) is a common condition being increasingly recognized and is associated with many diseases. Few data are available for Indian patients and public health hazard of the condition continues to be seriously underestimated in this country. The objective of this study was to evaluate the prevalence of obesity, hypertension, diabetes mellitus, and hyperlipidemia (HLP) in a South Indian population with proven OSA.

Methods: A retrospective analysis of data accrued in patients undergoing polysomnography (PSG) was undertaken. Two hundred thirty-four patients of either sex in the age of 54 ± 11 years who tested positive for OSA were compared with control group. An apnea-hypopnea index (AHI) of >5 in the presence of snoring and daytime somnolence was taken to define sleep apnea.

Results: The mean AHI among the study group with OSA was 31.3 ± 18.6 as compared with 1.2 ± 0.5 in the control group. The BMI among patients with OSA was 36 ± 6 as compared with 29 ± 4 in comparison group (p < 0.001). Among the patients with OSA, 31% were having HLP, 59% were diabetics, and 86% were hypertensive. Subjects with PSG-proven OSA had significant levels of day time sleepiness, lack of concentration, changes in mood, morning headache, and dry mouth. Nonrestorative sleep, awakening with choking, nocturnal dyspnea, insomnia with frequent awakenings, nocturia, and diaphoresis were observed in (>80%) patients. A significant difference in the sleep efficiency (16%), sleep onset (14%), and mean saturation (9%) was observed in the study group as compared to the control group.

Conclusions: The risk of obesity, hypertension, diabetes mellitus, and HLP in OSA syndrome patients was almost three times more than that of the comparing group.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Nasreen_2012,

title = {Glutamate decarboxylase and GABA aminotransferase levels in different regions of rat brain on the onset of leptazol induced convulsions},

author = {Zahida Nasreen and Tahmeen Jameel and Ashfaq Hasan and Parveen Naimath and B. Sadasivudu},

url = {https://link.springer.com/article/10.1007/s11064-011-0603-2},

doi = {10.1007/s11064-011-0603-2},

issn = {0364-3190},

year  = {2011},

date = {2011-09-21},

urldate = {2011-09-21},

journal = {Neurochemical Research},

volume = {37},

issue = {1},

pages = {202-204},

abstract = {The activities of Glutamate decarboxylase (GAD) and Gamma aminobutyric acid (GABA) were studied in three regions of rat brain in heightened neuronal activity resulting in convulsions by Leptazol. These enzymes were studied in preconvulsive, convulsive and post convulsive phases. The activity of GAD decreases significantly in the preconvulsive phase in all the three regions of brain followed by a significant increase during the convulsive and post convulsive phase in cerebral cortex and cerebellum. The activity of GABA-T decreases maximal during the preconvulsive phase followed by convulsive phase. The activity of this enzyme tended to increase to control values when the postconvulsive phase was reached. Therefore, it is suggested that the concomitant decrease of GAD activity and GABA concentration, is probably an important factor in the onset of convulsions.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Hasan_2011,

title = {Amyotrophic lateral sclerosis presenting with orthopnea in a patient with COPD and obstructive sleep apnea},

author = {Ashfaq Hasan and Amrit B. Saxena and Syed Mahmood Ahmed and T. L. N. Swamy},

url = {https://jmas.in/fulltext/154-1449470473.pdf?1698477675},

issn = {2231-1696},

year  = {2011},

date = {2011-01-31},

urldate = {2011-01-31},

journal = {Journal of Medical and Allied Sciences},

volume = {1},

issue = {1},

pages = {46-49},

abstract = {Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND) is a relentlessly progressive neurological disorder causing peripheral muscular weakness and resultant respiratory failure. In this article, we report a case of ALS with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) with orthopnea as initial symptoms.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}